Macular Degeneration vitamins antioxidants natural therapy with herbs

Age related macular degeneration can result in irreversible visual loss and is the commonest cause of blindness in the Western world. Macular degeneration may be recognized by a physician in its early stages by the appearance (with an ophtalmoscope) of pigment changes and drusen within the retina. The retina is particularly susceptible to oxidation as its need for oxygen is large, it is exposed to high levels of light, and its membranes are rich in readily oxidized polyunsaturated fatty acids, particularly
DHA found in fish oils. Eating fish or taking Fish oils supplements could reduce the risk for macular degeneration.  Smoking contributes to macular degeneration.
        Evidence from in vitro and animal studies suggests that the antioxidants
Natural Vitamin E complex
and Natural Vitamin C with bioflavonoids can protect the retina against photochemical damage.
Carotenoids also have antioxidant properties and two of these, Lutein and Zeazanthin, make up the macular pigment that is thought to limit retinal oxicative damage by filtering out blue light. Most, but not all, studies have shown that antioxidant supplements help reduce the progression of macular degeneration.

Omega 3 fatty acids for macular degeneration
High dietary levels of omega-3 long-chain polyunsaturated fatty acids and fish reduces the risk of age-related macular degeneration. Those with the highest levels of total omega-3 long-chain polyunsaturated fatty acids in their diet have a reduced risk of neovascular age-related macular degeneration compared with those with the lowest dietary levels. By contrast, intake of arachidonic acid, an omega-6 fatty polyunsaturated acid found in phospholipids, cell membrane and brain, increases the risk of neovascular age-related macular degeneration. These findings and those from other investigations suggest that modifying the diet to include more foods rich in omega-3 long-chain polyunsaturated fatty acids could lead a reduced risk of neovascular age-related macular degeneration. Archives of Ophthalmology, May 2007.

Lutein and zeaxanthin for macular degeneration
Macular degeneration is a condition in which there is progressive deterioration of the central area of the retina of the eye, resulting in gradual sight loss in the center of the field of vision. There are several carotenoids in the eye, the predominant ones being lutein and zeaxanthin. In a study of healthy women younger than 75 years, whose diets were rich in lutein and zeaxzanthin had a lower rate of age-related macular degeneration.
Lutein and zeaxanthin are found in green leafy vegetables, corn, and squash. Zeazanthin is also found in Goji berries.
   Many people limit their vegetable intake to a few of their favorites, such as carrots, tomatoes, lettuce, etc. It's important to have a wide variety in order to obtain various types of carotenoids.

Macular degeneration gene
A specific form of the apolipoprotein E (APOE) gene, called E2, increases the risk of age-related macular degeneration well beyond the age of 65, whereas another form of APOE called E4, may confer some protection.

Vitamins for macular degeneration prevention
Nutritional supplementation in age-related macular degeneration.
Curr Opin Ophthalmol. 2007 May;18(3):220-3. Coleman H, Chew E. Division of Epidemiology and Clinical Research, National Eye Institute/National Institutes of Health, Bethesda, Maryland, USA.
Persons with intermediate risk of age-related macular degeneration or advanced age-related macular degeneration in one eye are recommended to take the formulation proven in the Age-Related Eye Disease Study (AREDS) to be successful in preventing the development of advanced age-related macular degeneration by 25%. The formulation consists of vitamins C, E, beta-carotene and zinc. In addition, observational data suggest that high dietary intake of macular xanthophylls lutein and zeaxanthin are associated with a lower risk of advanced age-related macular degeneration. Similarly, long-chain polyunsaturated fatty acids derived from fish consumption are also associated with a decreased risk of advanced age-related macular degeneration. SUMMARY: Persons with intermediate age-related macular degeneration or advanced age-related macular degeneration (neovascular or central geographic atrophy) in one eye should consider taking the AREDS-type supplements. Further evaluation of nutritional factors, specifically, lutein zeaxanthin and omega-3 fatty acids will be tested in a multicenter controlled, randomized trial - the Age-Related Eye Disease Study 2 (AREDS2).

Macular Degeneration Research
Double-masked, placebo-controlled, randomized trial of lutein and antioxidant supplementation in the intervention of atrophic age-related macular degeneration: the Veterans LAST study (Lutein Antioxidant Supplementation Trial).
Richer S, Stiles W, Statkute L et al. Optometry. 2004;75:216-30.
Age-related macular degeneration is the leading cause of vision loss in aging Westem societies. The objective of the lutein antioxidant supplementation trial (LAST) is to determine whether nutritional supplementation with lutein or lutein together with antioxidants, vitamins, and minerals, improves visual function and symptoms in atrophic Age-related macular degeneration. The study was a prospective, 12-month, randomized, double-masked, placebo-controlled trial conducted at an urban midwestern Veterans Administration Hospital from August 1999 to May 2001. Ninety patients with atrophic macular degeneration were referred by ophthalmologists at two Chicago-area veterans medical facilities. Patients in Group 1 received lutein 10 mg (L); in Group 2, a lutein 10 mg/antioxidants/vitamins and minerals broad spectrum supplementation formula (L/A); and in Group 3, a maltodextrin placebo (P) over 12 months. In Groups 1 L and 2 L/A, mean eye macular pigment optical density increased approximately 0.09 log units from baseline, Snellen equivalent visual acuity improved 5.4 letters for Group 1 L and 3.5 letters for Group 2 L/A, and contrast sensitivity improved. There was a net subjective improvement in Amsler grid in Group 1 L. VFO-14 questionnaires conceming subjective glare recovery were nearly significant at 4 months for Group 2 L/A. Patients who received the placebo (Group 3) had no significant changes in any of the measured findings. In this study, visual function is improved with lutein alone or lutein together with other nutrients. Further studies are needed with more patients, of both genders, and for longer periods of time to assess long-term effects of lutein or lutein together with a broad spectrum of antioxidants, vitamins, and minerals in the treatment of atrophic age-related macular degeneration.

Inquiries
One website reports that vinpocetine could be helpful in treating wet macular degeneration, to help increase available oxygen to the eye. Eyesight Rx supplement does not list this as an ingredient. Do you believe it would be helpful. I am currently being treated for it in my right eye (about 7 months now), am receiving injections in the eye of anti-vegf factors and taking some additional supplements as well as, I believe, steroid drop in the eye, all prescribed by a retinal specialist. He seems open to alternative techniques, probably feeling the mostly likely wont hurt the situation. Have you any suggestions other than the vinpocetine specific for wet MD.
 

back to index yohimbe bark